Advanced microwave thermotherapy (PLFT®) as a method of choice in the treatment of complicated, inoperable prostatic adenoma


Cite item

Full Text

Abstract

The aim of our study was assessment of efficacy of PLFT technique on ProstaLund CoreTHerm unit in nanagement of acute urine retention in patients with prostatic adenoma. We treated 31 patients with prostatic adenoma (age 58-97, mean age 74 years, volume of the prostatic gland from 32 to 188 ml); 11 patients had suprapubic fistula, 8 carried urethral catheter for acute urinary retention. All the patients were inoperable because of a high surgical-anasthetic risk. All of them were exposed to PLFT for 9-15 min. Efficacy of the treatment was assessed by recovery of physiological urination, by IPSS tests and quality of life (QoL). PLFT destroyed 15 ± 5% prostatic tissue in each of the treated patients. The procedure was well tolerated. Physiological voiding was achieved in all the cases. Such complications typical for TUR as urethral stricture, vesical stenosis, urinary incontinence were not registered. On month 6 after the treatment QoL was assessed by the patients as 1-2 points, Qmax exceeded 15.2 ± 1.9 ml/s. Thus, PLFT is a highly effective and save treatment of prostatic adenoma and can be recommended as a standard management of patients with acute urinary retention at high surgical risk.

References

  1. Лоран О. Б., Вишневский Е. Л., Вишневский А. Е. Лечение расстройств мочеиспускания у больных доброкачественной гиперплазией простаты α-адреноблокаторами. М.: Медицина; 1998.
  2. de la Rosette J. J. Current status of thermotherapy of the prostate. J. Urol. (Baltimore) 1997; 157: 430.
  3. Schelin S. Mediating transurethral microwave thermotherapy by intraprostatic and periprostatic injections of mepivcaine epinephrine: effects ontreatment time, energy consumption and patient comfort. J. Endourol. 2002; 16 (2): 117-121.
  4. Schelin S., Claeson A., Sundin A., Wagrell L. Effects of intraprostatic and periprostatic injections of mepivacaine epinephrine on intraprostatic blood flow during transurethral microwave thermotherapy: correlations with [15O] H2O-PET. J. Endourol. 2004; 18 (10): 965-970.
  5. Mattiasson A., Wagrell L, Shelin S. et al. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: A prospective randomized multicenter study. Urology 2007; 69 (1): 91-96.
  6. Huidobro C., Bolmsjo M., Larson T. et al. Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping. J. Urol. 2004; 17: 672-678.
  7. Schelin S. Microwave thermotherapy in patients with benign prostatic hyperplasia and chronic urinary retention. Eur. J. Urol. 2001; 39: 400-404.
  8. Schelin S., Geertsen U., Walter S. et al. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study. Urology 2006; 68 (4): 795-799.
  9. Кривобородов Г. Г., Мазо Е. Б., Ефремов Н. С. "Мягкий" уретральный катетер-стент в диагностике причин нарушения опорожнения мочевого пузыря у мужчин с неврологическими заболеваниями. Урология 2009; 1: 13-16.
  10. Schelin S. Development of feedback microwave thermotherapy in symptomatic benign prostatic hyperplasia. PhD Theses. Lund; 2006.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies